DENTSPLY SIRONA Confirms Non-Emerging Growth Status in 8-K

TL;DR

**DENTSPLY SIRONA filed an 8-K confirming it's not an emerging growth company, meaning full SEC reporting.**

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on January 9, 2024, primarily to disclose that it is not an emerging growth company. This filing, under Items 2.02, 7.01, and 9.01, indicates the company is a well-established entity, trading on The Nasdaq Stock Market LLC under the symbol XRAY. For investors, this means DENTSPLY SIRONA is subject to full public company reporting requirements, offering more transparency than an emerging growth company, which can be a positive for due diligence.

Why It Matters

This filing clarifies DENTSPLY SIRONA's regulatory status, confirming it is a mature company subject to standard SEC reporting, which can reassure investors seeking established businesses.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of regulatory status and does not indicate any new financial or operational risks.

Analyst Insight

A smart investor would note this filing as a confirmation of DENTSPLY SIRONA's established status, implying greater regulatory scrutiny and transparency compared to an emerging growth company, which can be factored into their due diligence process.

Key Numbers

• $0.01 — Par value per share (The stated par value of DENTSPLY SIRONA's common stock.)

Key Players & Entities

• DENTSPLY SIRONA Inc. (company) — the registrant filing the 8-K
• The Nasdaq Stock Market LLC (company) — the exchange where DENTSPLY SIRONA's common stock is registered
• XRAY (company) — trading symbol for DENTSPLY SIRONA Inc.
• January 9, 2024 (date) — date of the earliest event reported and filing date
• $0.01 (dollar_amount) — par value per share of common stock

Forward-Looking Statements

• DENTSPLY SIRONA will continue to be subject to full SEC reporting requirements. (DENTSPLY SIRONA Inc.) — high confidence, target: Ongoing

FAQ

From the Filing

0000818479-24-000004.txt : 20240109 0000818479-24-000004.hdr.sgml : 20240109 20240109083028 ACCESSION NUMBER: 0000818479-24-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 30 CONFORMED PERIOD OF REPORT: 20240109 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 24521787 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20240109.htm 8-K xray-20240109 0000818479 false 0000818479 2024-01-09 2024-01-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 9, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of Principal Executive Offices) (Zip Code) ( 844) 848-0137 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 2.02. Results of Operations and Financial Condition DENTSPLY SIRONA Inc. (the “Company”) is providing preliminary unaudited selected results for the full year 2023 to facilitate the Company’s participation in the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 (the "Conference"). Based on preliminary financial information, the Company anticipates its estimated net sales for the year ended December 31, 2023 will be at or above the high end of its previously provided outlook range of $3.90 billion to $3.94 billion and reaffirms preliminary expectations for adjusted earnings per share (“EPS&#